4
Changes in Ownership
Vistagen Therapeutics, Inc. Filed Acc 0001415889-19-001357
PRES./CHIEF SCIENTIFIC OFFICER bought 15,000 shares at $0.34 ($5,100)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | 2019-11-20 | Purchase | +15,000 | $0.34 | $5,100 | 15,000 | I |
| Open-market purchases · 15,000 sh · avg $0.34 · $5,100 | |||||||
Loading xslF345X03/form4-11212019_041106.xml…